A major University of Birmingham bladder-cancer is being opened to wider and commercial development in the hope of speeding up better diagnostics and .

The resource contains data from tumour, blood and urine samples from more than 900 de-identified cases, linked to information and between five and 15 years of follow-up.

The data has already helped generate new biological insights and tests. Making it available through Cancer Research Horizons could support new biomarkers, patient stratification and more personalised approaches.

Medical datasets are not photogenic breakthroughs. They are more like a carefully labelled library. The value comes when enough can finally find the page they needed.